A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

Summary

This study will be conducted in participants with type 1 diabetes mellitus to investigate how the human body processes LY900014, a new blood sugar lowering insulin, and its effect on blood sugar levels when it is delivered via an insulin pump. Side effects and tolerability will be documented. The study will last about 4 to 11 weeks for each participant.

Timeline

Start

2017-02-23

Primary completion

2017-06-19

Completion

2017-06-19

Drugs

Indications